Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal disease.

× No keyword cloud information.

13 in total

1. Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.

Authors: Ira L Leeds; Vasanthkumar Namasivayam; Assanatou Bamogo; Prithvi Sankhla; Winter M Thayer
Journal: Am J Prev Med Date: 2018-12-17 Impact factor: 5.043

Review 2. Regulation of capsule in Neisseria meningitidis.

Authors: Yih-Ling Tzeng; Jennifer Thomas; David S Stephens
Journal: Crit Rev Microbiol Date: 2015-06-19 Impact factor: 7.624

3. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.

Authors: Serena Giuntini; David M Vu; Dan M Granoff
Journal: Vaccine Date: 2013-06-17 Impact factor: 3.641

Review 4. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?

Authors: Dan M Granoff; Sanjay Ram; Peter T Beernink
Journal: Clin Vaccine Immunol Date: 2013-06-05

5. Acceptability of meningococcal serogroup B vaccine among parents and health care workers in Italy: a survey.

Authors: Chiara Mameli; Marino Faccini; Cristina Mazzali; Marina Picca; Giacomo Colella; Pier Giorgio Duca; Gian Vincenzo Zuccotti
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

6. Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines.

Authors: Monica Konar; Dan M Granoff; Peter T Beernink
Journal: J Infect Dis Date: 2013-05-28 Impact factor: 5.226

Review 7. Meningococcal group B vaccines.

Authors: Jamie Findlow
Journal: Hum Vaccin Immunother Date: 2013-06-06 Impact factor: 3.452

8. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.

Authors: Raffaella Rossi; Dan M Granoff; Peter T Beernink
Journal: Vaccine Date: 2013-09-11 Impact factor: 3.641

9. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.

Authors: Rolando Pajon; Andrew M Fergus; Dan M Granoff
Journal: PLoS One Date: 2013-06-21 Impact factor: 3.240

10. Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein.

Authors: Peter T Beernink
Journal: Hum Vaccin Immunother Date: 2019-10-22 Impact factor: 3.452